Published: 13 January 2015
Author(s): Maria Pilar Villanueva, Anna Mollar, Patricia Palau, Arturo Carratalá, Eduardo Núñez, Enrique Santas, Vicent Bodí, Francisco J. Chorro, Gema Miñana, Maria L. Blasco, Juan Sanchis, Julio Núñez
Section: Original Article

Traditionally, procalcitonin (PCT) is considered a diagnostic marker of bacterial infections. However, slightly elevated levels of PCT have also been found in patients with heart failure. In this context, it has been suggested that PCT may serve as a proxy for underrecognized infection, endotoxemia, or heightened proinflammatory activity. Nevertheless, the clinical utility of PCT in this setting is scarce. We aimed to evaluate the association between PCT and the risk of long-term outcomes.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.